Canine Oral Chewable Tablets Market: By Composition Type, By Drug Class, By Application, By Product Type ), By Distribution Channel and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Canine Oral Chewable Tablets Market Size, Share, Growth, Trends, and Global Industry Analysis: By Composition Type (Botanically synthesized, Chemically synthesized), By Drug Class (Analgesics, Anti-infective, Anti-ulcers, Vitamins & minerals, Cardiovascular drugs, Others), By Application (Gastrointestinal diseases, Cardiovascular disorders, Infectious diseases, Nutritional supplements, Others), By Product Type (Prescription, Over the Counter (OTC)), By Distribution Channel (Veterinary clinics, Veterinary Pharmacies, Online veterinary stores, Others) and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Canine Oral Chewable Tablets Market size was valued at US$ X million in 2023 and is poised to grow at a CAGR of x% from 2024 - 2030. The market is an oral dosage form of medication with additives used to treat various types of canine diseases such as arthritis, canine congestive heart failure, tick and flea infections, and among others. Various additives and flavoring agents are used in the formulation of canine oral chewable tablets to mask the unpleasant taste and odor of the drugs.

The canine oral chewable tablets will dissolve in 2-5 minutes and the pharmacological action takes place immediately. The global market is in the developing stage as several local and international players are actively engaged in the manufacturing of canine oral chewable tablets for the treatment of chronic canine diseases. Acquisitions and mergers, collaborations, joint ventures, and product launches, are some key strategies followed by the manufacturers for increasing their share in the global market.  

Canine Oral Chewable Tablets Market Key Developments: 

  • in May 2014, Merck Animal Health received the FDA approval for its drug Bravecto (fluralaner) used in the treatment of fleas and ticks infections. Moreover,
  • in December 2014, Putney, Inc. launched the Carprofen canine oral chewable tablets for the treatment of pain and inflammation.

summary download arrow Download Free Sample

Global Canine Oral Chewable Tablets Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

X%

Largest Market

Asia-Pacific

Fastest Growing Market

North America

Canine Oral Chewable Tablets Market Dynamics

Rise in the expenditure in animal welfare and wellness, wider availability of the canine oral chewable tablets in the market, and rise in the prevalence of various canine diseases such as tick and fleas infections, anticipated to fuel the global market over the forecast period. In addition, ease of administration of tablets compared with parenteral formulations, lack of nutrition values in the canine feed, and initiations taken by various pet organizations and NGOs for animal welfare are expected bolster the canine oral chewable tablets market over the forecast years.

However, stringent regulatory policies for the approval of veterinary formulations, lack of awareness about the canine oral chewable tablets in rural areas, high cost of the products, and withdrawn of drugs from the market such as levothyroxine sodium due to FDA warning regarding the lack of approval might hinder the global market growth in the coming future.

Global Canine Oral Chewable Tablets Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market CAGR

X%

By Composition Type

  • Botanically synthesized
  • Chemically synthesized

By Drugs Type

  • Analgesics
  • Anti-infective
  • Anti-ulcers
  • Vitamins & minerals
  • Cardiovascular drugs
  • Others

By Application

  • Gastrointestinal diseases
  • Cardiovascular disorders
  • Infectious diseases
  • Nutritional supplements
  • Others

By Distribution Channel

  • Veterinary clinics
  • Veterinary Pharmacies
  • Online veterinary stores
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The canine oral chewable tablets market report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global canine oral chewable tablets market size was valued at US$ x million in 2023 and is projected to grow at a CAGR of x% from 2024 to 2030.

The market key players are: Zoetis, Inc. (Pfizer) (U.S) Virbac AH Inc. (France) Elanco (Eli Lilly and Co.) (U.S.) Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany) Pala-Tech Laboratories (U.S.) Bayer HealthCare LLC, (Bayer AG) (Germany) Merck Animal Health (Merck &co. Inc.) (U.S.) Putney, Inc. (Dechra Pharmaceuticals) (U.K.)

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Canine Oral Chewable Tablets Market Introduction 
2.1.Global Canine Oral Chewable Tablets Market  - Taxonomy
2.2.Global Canine Oral Chewable Tablets Market  - Definitions
2.2.1.Composition Type
2.2.2.Drugs Type
2.2.3.Application
2.2.4.Distribution Channel
2.2.5.Region
3. Global Canine Oral Chewable Tablets Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Canine Oral Chewable Tablets Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Canine Oral Chewable Tablets Market  By Composition Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Botanically synthesized
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Chemically synthesized
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6. Global Canine Oral Chewable Tablets Market  By Drugs Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Analgesics
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Anti-infective
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Anti-ulcers
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Vitamins & minerals
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Cardiovascular drugs
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Others
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
7. Global Canine Oral Chewable Tablets Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Gastrointestinal diseases
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Cardiovascular disorders
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Infectious diseases
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Nutritional supplements
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Others
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. Global Canine Oral Chewable Tablets Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Veterinary clinics
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Veterinary Pharmacies
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Online veterinary stores
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Global Canine Oral Chewable Tablets Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Canine Oral Chewable Tablets Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Composition Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Botanically synthesized
10.1.2.Chemically synthesized
10.2.  Drugs Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Analgesics
10.2.2.Anti-infective
10.2.3.Anti-ulcers
10.2.4.Vitamins & minerals
10.2.5.Cardiovascular drugs
10.2.6.Others
10.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Gastrointestinal diseases
10.3.2.Cardiovascular disorders
10.3.3.Infectious diseases
10.3.4.Nutritional supplements
10.3.5.Others
10.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Veterinary clinics
10.4.2.Veterinary Pharmacies
10.4.3.Online veterinary stores
10.4.4.Others
10.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Canine Oral Chewable Tablets Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Composition Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Botanically synthesized
11.1.2.Chemically synthesized
11.2.  Drugs Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Analgesics
11.2.2.Anti-infective
11.2.3.Anti-ulcers
11.2.4.Vitamins & minerals
11.2.5.Cardiovascular drugs
11.2.6.Others
11.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Gastrointestinal diseases
11.3.2.Cardiovascular disorders
11.3.3.Infectious diseases
11.3.4.Nutritional supplements
11.3.5.Others
11.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Veterinary clinics
11.4.2.Veterinary Pharmacies
11.4.3.Online veterinary stores
11.4.4.Others
11.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Canine Oral Chewable Tablets Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Composition Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Botanically synthesized
12.1.2.Chemically synthesized
12.2.  Drugs Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Analgesics
12.2.2.Anti-infective
12.2.3.Anti-ulcers
12.2.4.Vitamins & minerals
12.2.5.Cardiovascular drugs
12.2.6.Others
12.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Gastrointestinal diseases
12.3.2.Cardiovascular disorders
12.3.3.Infectious diseases
12.3.4.Nutritional supplements
12.3.5.Others
12.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Veterinary clinics
12.4.2.Veterinary Pharmacies
12.4.3.Online veterinary stores
12.4.4.Others
12.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Canine Oral Chewable Tablets Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Composition Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Botanically synthesized
13.1.2.Chemically synthesized
13.2.  Drugs Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Analgesics
13.2.2.Anti-infective
13.2.3.Anti-ulcers
13.2.4.Vitamins & minerals
13.2.5.Cardiovascular drugs
13.2.6.Others
13.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Gastrointestinal diseases
13.3.2.Cardiovascular disorders
13.3.3.Infectious diseases
13.3.4.Nutritional supplements
13.3.5.Others
13.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Veterinary clinics
13.4.2.Veterinary Pharmacies
13.4.3.Online veterinary stores
13.4.4.Others
13.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Canine Oral Chewable Tablets Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14.1. Composition Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Botanically synthesized
14.1.2.Chemically synthesized
14.2.  Drugs Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Analgesics
14.2.2.Anti-infective
14.2.3.Anti-ulcers
14.2.4.Vitamins & minerals
14.2.5.Cardiovascular drugs
14.2.6.Others
14.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Gastrointestinal diseases
14.3.2.Cardiovascular disorders
14.3.3.Infectious diseases
14.3.4.Nutritional supplements
14.3.5.Others
14.4.  Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Veterinary clinics
14.4.2.Veterinary Pharmacies
14.4.3.Online veterinary stores
14.4.4.Others
14.5.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Zoetis, Inc. (Pfizer) (U.S)
15.2.2.Virbac AH Inc. (France)
15.2.3.Elanco (Eli Lilly and Co.) (U.S.)
15.2.4.Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany)
15.2.5.Pala-Tech Laboratories (U.S.)
15.2.6.Bayer HealthCare LLC, (Bayer AG) (Germany)
15.2.7.Merck Animal Health (Merck &co. Inc.) (U.S.)
15.2.8.Putney, Inc. (Dechra Pharmaceuticals) (U.K.)
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Zoetis, Inc. (Pfizer) (U.S)
  • Virbac AH Inc. (France)
  • Elanco (Eli Lilly and Co.) (U.S.)
  • Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany)
  • Pala-Tech Laboratories (U.S.)
  • Bayer HealthCare LLC, (Bayer AG) (Germany)
  • Merck Animal Health (Merck &co. Inc.) (U.S.)
  • Putney, Inc. (Dechra Pharmaceuticals) (U.K.)

Related Industry Reports

Canine Orthopedics Market

Oral Contraceptive Pills Market

Oral Biofilm Therapeutics Market

Global Canine Leishmaniasis Management Market